Sapphire Star Partners’s Eli Lilly LLY Stock Holding History

Sapphire Star Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$668K	Sell	5,773 -427	-7%	-$47.7K	0.89%	40
2018 Q3	$665K	Sell	6,200 -500	-7%	-$50K	0.67%	58
2018 Q2	$572K	Buy	6,700 +81	+1%	+$6.65K	0.59%	63
2018 Q1	$511K	Sell	6,619 -200	-3%	-$16.1K	0.56%	66
2017 Q4	$576K	Sell	6,819 -4,500	-40%	-$383K	0.68%	51
2017 Q3	$968K	Sell	11,319 -3,981	-26%	-$327K	1.25%	21
2017 Q2	$1.26M	Sell	15,300 -800	-5%	-$65.3K	1.59%	18
2017 Q1	$1.35M	Sell	16,100 -400	-2%	-$32K	1.54%	18
2016 Q4	$1.21M	Sell	16,500 -1,357	-8%	-$101K	1.35%	20
2016 Q3	$1.43M	Sell	17,857 -517	-3%	-$41.4K	1.73%	18
2016 Q2	$1.45M	Sell	18,374 -15,448	-46%	-$1.16M	1.85%	16
2016 Q1	$2.85M	Buy	33,822 +16,911	+100%	+$1.28M	2.26%	14
2015 Q4	$1.43M	Buy	+16,911	New	+$1.4M	1.89%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sapphire Star Partners's LLY Position: Q4 2018 in Review

Sapphire Star Partners reduced its Eli Lilly (LLY) stake by 6.9% in Q4 2018, selling an estimated $47.7K and leaving 5,773 shares worth $668K. The position accounts for 0.89% of the portfolio, ranked #40.

Sapphire Star Partners first reported a position in LLY in Q4 2015 and has held it in 13 quarters since. The position peaked at $2.85M in Q1 2016. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Sapphire Star Partners held 5,773 shares of Eli Lilly worth $668K as of Q4 2018.
Sapphire Star Partners sold 427 Eli Lilly shares in Q4 2018, an estimated $47.7K.
Eli Lilly made up 0.89% of Sapphire Star Partners's portfolio in Q4 2018, its #40 holding.
Sapphire Star Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 13 quarters since.
Sapphire Star Partners's Eli Lilly position peaked at $2.85M in Q1 2016.
1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.